• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荷兰一家医院中耐甲氧西林金黄色葡萄球菌(MRSA)筛查与清除政策的成本与效益

Costs and benefits of the MRSA Search and Destroy policy in a Dutch hospital.

作者信息

van Rijen M M L, Kluytmans J A J W

机构信息

Laboratory for Microbiology and Infection Control, Amphia Hospital Breda, Langendijk 75, P.O. Box 90157, 4800 RL, Breda, The Netherlands.

出版信息

Eur J Clin Microbiol Infect Dis. 2009 Oct;28(10):1245-52. doi: 10.1007/s10096-009-0775-8. Epub 2009 Jul 18.

DOI:10.1007/s10096-009-0775-8
PMID:19618223
Abstract

The objective of this study was to determine the costs and benefits of the MRSA Search and Destroy policy in a Dutch hospital during 2001 through 2006. Variable costs included costs for isolation, contact tracing, treatment of carriers and closure of wards. Fixed costs were the costs for the building of isolation rooms and the salary of one full-time infection control practitioner. To determine the benefits of the Search and Destroy policy, the transmission rate during the study period was calculated. Furthermore, the number of cases of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia prevented was estimated, as well as its associated prevented costs and patient lives. The costs of the MRSA policy were estimated to be euro 215,559 a year, which equals euro 5.54 per admission. The daily isolation costs for MRSA-suspected and -positive hospitalised patients were euro 95.59 and euro 436.62, respectively. Application of the Search and Destroy policy resulted in a transmission rate of 0.30 and was estimated to prevent 36 cases of MRSA bacteraemia per year, resulting in annual savings of euro 427,356 for the hospital and ten lives per year (95% confidence interval [CI] 8-14). In conclusion, application of the MRSA Search and Destroy policy in a hospital in a country with a low endemic MRSA incidence saves money and lives.

摘要

本研究的目的是确定2001年至2006年期间荷兰一家医院实施耐甲氧西林金黄色葡萄球菌(MRSA)筛查与清除政策的成本和效益。可变成本包括隔离、接触者追踪、携带者治疗和病房关闭的成本。固定成本是隔离病房建设成本和一名全职感染控制从业人员的工资。为了确定筛查与清除政策的效益,计算了研究期间的传播率。此外,还估算了预防的耐甲氧西林金黄色葡萄球菌(MRSA)菌血症病例数及其相关的预防成本和挽救的患者生命数。MRSA政策的成本估计为每年215,559欧元,相当于每次住院5.54欧元。疑似和确诊MRSA的住院患者的每日隔离成本分别为95.59欧元和436.62欧元。实施筛查与清除政策导致传播率为0.30,估计每年可预防36例MRSA菌血症,为医院每年节省427,356欧元,并每年挽救10条生命(95%置信区间[CI] 8 - 14)。总之,在MRSA地方发病率较低的国家,在医院实施MRSA筛查与清除政策可节省资金并挽救生命。

相似文献

1
Costs and benefits of the MRSA Search and Destroy policy in a Dutch hospital.荷兰一家医院中耐甲氧西林金黄色葡萄球菌(MRSA)筛查与清除政策的成本与效益
Eur J Clin Microbiol Infect Dis. 2009 Oct;28(10):1245-52. doi: 10.1007/s10096-009-0775-8. Epub 2009 Jul 18.
2
Cost of the meticillin-resistant Staphylococcus aureus search and destroy policy in a Dutch university hospital.荷兰一家大学医院中耐甲氧西林金黄色葡萄球菌筛查与清除策略的成本
J Hosp Infect. 2008 Apr;68(4):301-7. doi: 10.1016/j.jhin.2008.01.018. Epub 2008 Mar 19.
3
Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey.荷兰一家大学医学中心实施根除耐甲氧西林金黄色葡萄球菌严格政策的相关成本:一项为期10年的调查。
Eur J Clin Microbiol Infect Dis. 2002 Nov;21(11):782-6. doi: 10.1007/s10096-002-0811-4. Epub 2002 Nov 8.
4
5 years of experience implementing a methicillin-resistant Staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands.在荷兰最大的大学医学中心实施耐甲氧西林金黄色葡萄球菌筛查与清除政策5年的经验。
Infect Control Hosp Epidemiol. 2009 Oct;30(10):977-84. doi: 10.1086/605921.
5
Costs and Benefits Associated with the MRSA Search and Destroy Policy in a Hospital in the Region Kennemerland, The Netherlands.荷兰肯内梅林地区一家医院与耐甲氧西林金黄色葡萄球菌“搜索并消灭”政策相关的成本与效益
PLoS One. 2016 Feb 5;11(2):e0148175. doi: 10.1371/journal.pone.0148175. eCollection 2016.
6
Search and destroy policy for methicillin-resistant Staphylococcus aureus: cost-benefit analysis.耐甲氧西林金黄色葡萄球菌的搜索与清除策略:成本效益分析
J Adv Nurs. 2009 Sep;65(9):1853-9. doi: 10.1111/j.1365-2648.2009.05050.x.
7
Cost Analysis of an Intervention to Prevent Methicillin-Resistant Staphylococcus Aureus (MRSA) Transmission.预防耐甲氧西林金黄色葡萄球菌(MRSA)传播干预措施的成本分析
PLoS One. 2015 Sep 25;10(9):e0138999. doi: 10.1371/journal.pone.0138999. eCollection 2015.
8
Review of a major epidemic of methicillin-resistant Staphylococcus aureus: the costs of screening and consequences of outbreak management.耐甲氧西林金黄色葡萄球菌(MRSA)重大疫情回顾:筛查成本和疫情管理后果。
Am J Infect Control. 2013 Mar;41(3):204-9. doi: 10.1016/j.ajic.2012.02.033. Epub 2012 Aug 21.
9
[The Dutch MRSA policy should be retained].应保留荷兰的耐甲氧西林金黄色葡萄球菌(MRSA)政策。
Ned Tijdschr Geneeskd. 2006 Aug 26;150(34):1884.
10
Costs of healthcare-associated methicillin-resistant Staphylococcus aureus and its control.医疗保健相关耐甲氧西林金黄色葡萄球菌及其控制的成本。
Clin Microbiol Infect. 2010 Dec;16(12):1721-8. doi: 10.1111/j.1469-0691.2010.03365.x. Epub 2010 Nov 5.

引用本文的文献

1
Investigating the implementation of infection prevention and control practices in neonatal care across country income levels: a systematic review.调查不同国家收入水平下新生儿护理中感染预防与控制措施的实施情况:一项系统综述
Antimicrob Resist Infect Control. 2025 Feb 7;14(1):8. doi: 10.1186/s13756-025-01516-7.
2
Exploring the Barriers in the Uptake of the Dutch MRSA 'Search and Destroy' Policy Using the Cascade of Care Approach.使用护理级联方法探索荷兰耐甲氧西林金黄色葡萄球菌“搜索并消灭”政策实施过程中的障碍。
Antibiotics (Basel). 2022 Sep 8;11(9):1216. doi: 10.3390/antibiotics11091216.
3
Comparing optimization criteria in antibiotic allocation protocols.

本文引用的文献

1
[Optimisation of the antibiotic policy in the Netherlands. XII. The SWAB guideline for antimicrobial eradication of MRSA in carriers].[荷兰抗生素政策的优化。十二。关于携带者中耐甲氧西林金黄色葡萄球菌抗菌清除的SWAB指南]
Ned Tijdschr Geneeskd. 2008 Dec 6;152(49):2667-71.
2
Cost of the meticillin-resistant Staphylococcus aureus search and destroy policy in a Dutch university hospital.荷兰一家大学医院中耐甲氧西林金黄色葡萄球菌筛查与清除策略的成本
J Hosp Infect. 2008 Apr;68(4):301-7. doi: 10.1016/j.jhin.2008.01.018. Epub 2008 Mar 19.
3
Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans.
比较抗生素分配方案中的优化标准。
R Soc Open Sci. 2022 Mar 23;9(3):220181. doi: 10.1098/rsos.220181. eCollection 2022 Mar.
4
Measuring perception of mental well-being in patients under isolation precautions: a prospective comparative study.测量采取隔离预防措施患者的心理健康感知:一项前瞻性对照研究。
BMJ Open. 2022 Mar 21;12(3):e044639. doi: 10.1136/bmjopen-2020-044639.
5
Development and validation of a time and motion guide to assess the costs of prevention and control interventions for nosocomial infections: A Delphi method among experts.开发和验证时间和动作指南,以评估预防和控制医院感染干预措施的成本:专家德尔菲法。
PLoS One. 2020 Nov 12;15(11):e0242212. doi: 10.1371/journal.pone.0242212. eCollection 2020.
6
Economic analysis of healthcare-associated infection prevention and control interventions in medical and surgical units: systematic review using a discounting approach.医疗和外科单位中预防和控制医院感染的经济分析:使用折扣方法进行系统评价。
J Hosp Infect. 2020 Sep;106(1):134-154. doi: 10.1016/j.jhin.2020.07.004. Epub 2020 Jul 8.
7
One Health in hospitals: how understanding the dynamics of people, animals, and the hospital built-environment can be used to better inform interventions for antimicrobial-resistant gram-positive infections.医院里的One Health:了解人与动物、医院建筑环境的动态如何能够更好地为抗微生物药物耐药革兰阳性菌感染干预措施提供信息。
Antimicrob Resist Infect Control. 2020 Jun 1;9(1):78. doi: 10.1186/s13756-020-00737-2.
8
Changing epidemiology of methicillin-resistant Staphylococcus aureus in a low endemicity area-new challenges for MRSA control.耐甲氧西林金黄色葡萄球菌在低流行地区的流行病学变化——耐甲氧西林金黄色葡萄球菌控制的新挑战。
Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2299-2307. doi: 10.1007/s10096-020-03824-9. Epub 2020 Jan 27.
9
Policy implementation for methicillin-resistant in seven European countries: a comparative analysis from 1999 to 2015.七个欧洲国家耐甲氧西林金黄色葡萄球菌的政策实施情况:1999年至2015年的比较分析
J Mark Access Health Policy. 2017 Jul 26;5(1):1351293. doi: 10.1080/20016689.2017.1351293. eCollection 2017.
10
Communicating the Risk of MRSA: The Role of Clinical Practice, Regulation and Other Policies in Five European Countries.传播耐甲氧西林金黄色葡萄球菌(MRSA)的风险:临床实践、监管及其他政策在五个欧洲国家所起的作用。
Front Public Health. 2017 Mar 17;5:44. doi: 10.3389/fpubh.2017.00044. eCollection 2017.
动物源耐甲氧西林金黄色葡萄球菌在人类中的出现。
Emerg Infect Dis. 2007 Dec;13(12):1834-9. doi: 10.3201/eid1312.070384.
4
Increase in a Dutch hospital of methicillin-resistant Staphylococcus aureus related to animal farming.荷兰一家医院中耐甲氧西林金黄色葡萄球菌的增加与畜牧业有关。
Clin Infect Dis. 2008 Jan 15;46(2):261-3. doi: 10.1086/524672.
5
Invasive methicillin-resistant Staphylococcus aureus infections in the United States.美国侵袭性耐甲氧西林金黄色葡萄球菌感染
JAMA. 2007 Oct 17;298(15):1763-71. doi: 10.1001/jama.298.15.1763.
6
Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study.1997 - 2003年牛津郡两家医院金黄色葡萄球菌菌血症后的死亡率:队列研究
BMJ. 2006 Aug 5;333(7562):281. doi: 10.1136/bmj.38834.421713.2F. Epub 2006 Jun 23.
7
Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing.控制耐甲氧西林金黄色葡萄球菌:量化干预措施和快速诊断检测的效果。
Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5620-5. doi: 10.1073/pnas.0510077103. Epub 2006 Mar 24.
8
Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives.社区获得性耐甲氧西林金黄色葡萄球菌:当前观点
Clin Microbiol Infect. 2006 Mar;12 Suppl 1:9-15. doi: 10.1111/j.1469-0691.2006.01341.x.
9
Staphylococcus aureus bacteremia, Europe.欧洲的金黄色葡萄球菌菌血症
Emerg Infect Dis. 2005 Nov;11(11):1798-9. doi: 10.3201/eid1111.050524.
10
The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges.金黄色葡萄球菌菌血症中耐甲氧西林对患者预后的影响:死亡率、住院时间和住院费用。
Infect Control Hosp Epidemiol. 2005 Feb;26(2):166-74. doi: 10.1086/502522.